Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Scivita Closes $61 Million Round for Advanced Endoscopy Products

publication date: Aug 20, 2021

Scivita Medical Technology of Suzhou closed a $61 million Series B round to continue development of its endoscopy products. Scivita's products include flexible and rigid endoscopy devices that feature ultra-high-definition visualization (such as 4K UHD visualization), 3D visualization , special optical imaging (such as fluorescence imaging), ultra-fine endoscopic imaging and endoscopic consumables. The funding included Hudson Bay Capital Management and Prime Capital. Scivita completed an A round of undisclosed size earlier this year. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital